Page 1314 - Reuters/workspace/business Standard Web/video

Adidas expects to bounce back to profitability in Q3 after pandemic hit

Adidas said its sales were flat for the second quarter in China, where it saw double-digit growth in May and June

Oil prices under five-month highs on weaker dollar, low US crude inventory

Brent crude fell 7 cents to $45.10 a barrel by 0802 GMT, while US crude was down 25 cents at $41.94

AstraZeneca in deal with Kangtai Bio to supply Covid-19 vaccine in China

AstraZeneca signed an exclusive framework agreement with China's Shenzhen Kangtai Biological Products to supply its Covid-19 vaccine candidate in mainland China

Toyota ekes out weakest Q1 profit in 9 years as pandemic halves car sales

Toyota's operating profit plunged 98% to 13.9 billion yen ($131.73 million) for the three months ended June

India must look beyond what rating agencies think, says Raghuram Rajan

RBI needs to focus on whether credit is reaching the stressed areas of the economy and also if the viable firms were able to access credit and not the unviable ones, he says

New York prosecutors subpoenaed Deutsche Bank in Trump probe: Report

The prosecutors issued the subpoena last year, seeking financial records that the Republican president and his company had provided to the bank, the Times said, citing four unnamed people

South Korea's Posco set to supply LNG to Pakistan for first time: Report

Posco offered the lowest bid of 7.9673% of Brent crude oil prices for the supply of an LNG cargo into Pakistan

US FDA approves GlaxoSmithKline's experimental drug for blood cancer

Multiple myeloma is the second most common form of blood cancer in the US and is generally considered treatable, but not curable

Fed policymakers say pickup in infections slowing US economic recovery

The increase in infections has raised the downside risks to the economic outlook and suggests the reopening of the U.S. economy may be more protracted

Oil prices rise to 5-month high on weak dollar, US crude stockpiles

Oil also drew support from signs that talks between the White House and Democrats in Congress on a new coronavirus relief package are making progress, although the sides remain far apart

Novavax signs Covid-19 vaccine supply deal with India's Serum Institute

The Indian drugmaker will have exclusive rights for the vaccine in India during the term of the deal

US to pay over $1 bn for 100 mn doses of J&J's potential Covid-19 vaccine

J&J has already received $1 billion in funding from the US

Disney takes $5-bn hit but Covid-19 pandemic impact not as bad as feared

Disney's quarterly profit of 8 cents per share on an adjusted basis beat expectations for a loss of 64 cents, sending the stock up 5 per cent in after-market trade

After Beirut blast claims over 100 lives, a search for answers & survivors

Explosion caused by the detonation of 2,750 tonnes of ammonium nitrate stored in a warehouse, say officials

Trump's bid for a piece of Microsoft-TikTok deal could spur legal action

US law states that presidential decisions blocking deals on national security grounds are not subject to judicial reviews

CVS raises profit forecast, in talks with US to administer Covid vaccines

CVS also said it was working with laboratories to cut down the turnaround time for coronavirus test results, which had spiked in July due to a massive increase in demand for tests

Wall Street gains on Disney's surprise profit, Covid-19 fiscal aid hopes

White House negotiators on Tuesday vowed to work "around the clock" with congressional Democrats to try to reach a deal on the package by the end of this week

US job market recovery appears to be slowing, services sector rising ahead

While other data on Wednesday showed activity in the vast services sector gained momentum in July as new orders raced to a record high, hiring declined

Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook

The company also released with Regeneron Pharmaceuticals results for advanced trials for pain medication fasinumab

Moderna prices Covid vaccine at $32-$37 per dose for smaller volume deals

As the race to develop Covid-19 vaccines reach a decisive stage, with several candidates being tested in pivotal late-stage studies, pricing has come under increasing scrutiny.